Subscribe
1 February 2012Jurisdiction reportsAurelia Marie

Generic drugs: a bitter pill to swallow

Law 2011-2012 of December 29, 2011, relating to the reinforcement of the safety of drugs and medicinal products, has modified the Code de la Santé Publique (CSP, the French public health code). It includes two articles that affect the extent of the exclusive rights of intellectual property owners.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk




Editor's picks

AI, lipstick deals and mental health: What’s on CITMA president’s radar?
Trademarks
AI, lipstick deals and mental health: What’s on CITMA president’s radar?
9 May 2025

Editor's picks

Trademarks
AI, lipstick deals and mental health: What’s on CITMA president’s radar?
9 May 2025
Patents
US-China tariffs: What hope is there for IP rightsholders?
1 May 2025
Trademarks
Thatchers, Skykick and dupes: What’s on a fashion IP influencer’s radar?
30 April 2025
Patents
Why US patent reform is ‘essential’ for US economic prosperity and security
28 April 2025
Patents
G1/23 ruling: Why a pending EPO decision threatens decade-old products
28 April 2025
Diversity
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
23 April 2025

More articles

AI, lipstick deals and mental health: What’s on CITMA president’s radar?
A welcome change: Sweden’s new patent act
IP and the commercialisation of genomic tech in Nigeria
UPC weighs ‘long-arm’, Samsung, Fujifilm disputes
Country briefing: Trademark prosecution in India
Top contenders for inaugural life sciences awards revealed
Clifford Chance expands IP team with A&O Shearman hire
Morgan Lewis expands team with five-partner hire